CHIMENCT07947095
Investigating the Effectiveness of Calisda, a Digital Health Intervention for Patients With Menopause Symptoms
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
29-item Menopause-Specific Quality of Life Questionnaire (MENQOL; 1-week recall) total score
Timeframe: 6 months
Secondary (4)
Hot Flash Related Daily Interference Scale (HFRDIS) total score
Insomnia Severity Index (ISI) total score
Patient Health Questionnaire (PHQ-9) total score
Menopause Rating Scale II (MRS-II) total score
Arms and interventions
calisdaExperimental
Participants will receive access to the digital health intervention calisda in addition to TAU.
Control groupNo intervention
Participants allocated to the control group will receive access to treatment as usual (TAU).
Behavioral: calisda
Sites
1 site in 1 country
- GAIA AGHamburg, Germany